Select your products and services :
Select your country :
Asia and South Pacific
Middle East and Africa

Update your choices | BU : Life Science | Country : USA

Boost your hybridomas


Our exclusive production protocol boosts hybridoma productivity (from 20% to 600% increase recorded so far). The production and purification steps are performed under optimized conditions. This allows the collection of an increased amount of monoclonal antibodies

We propose the following services, where we can evaluate the productivity of your hybridoma, then perform a mAb production in this boosted condition; A productivity report can be generated.

High mAb quantity   Your clone productivity   Hybridoma productivity
Get very high
mAb quantity
  Know more about
your clone productivity
  Learn how we can boost
your hybridoma’s productivity
You receive a pool of purified IgGs from classical and boosted production
+ a free cryovial of your hybridoma.
  We measure the productivity of your Hybridoma under normal and boosted conditions.   Our proprietary protocol may increase up to 7 fold the productivity of your hybridoma.

For 2850 EUR / 2590 GBP / 3250 CHF *

Interested to test these conditions on your hybridomas?

  Contact us  

Program includes:

1. In vitro mAB production

Production in parallel under classical and boosted conditions each in 1 x 650 mL roller bottle.

→ You receive a free cryovial of your hybridoma

hybridoma petridish

2. Productivity measurement

mAb productivity comparison by ELISA from the supernatant of each roller bottle.

→ You receive the productivity ratio between conditions

3. Purification

Total IgG purification by Protein G from the pooled supernatant of both roller bottles.

→ You receive your purified monoconal antibody

Increased hybridoma productivity

Hybridoma selection is generally based on the specificity and the quantity of generated monoclonal antibodies. In some instances, certain highly specific and interesting mAbs are produced in low amounts, necessitating multiple production runs to obtain significant amount of material, which in turn would generate high production costs.

To improve productivity of low yield hybridomas, we have developed an in-house optimized protocol that has already shown an increase of productivity up to 7 fold.

Boosted conditions have made all hybridomas (even “good producers”) able to produce larger amounts of antibodies per batch thereby reducing production costs.

Antibody production


In addition, our protocol showed a high reproducibility in antibody production.

Reproductibility of antibody production

Interested in our exclusive offer ?

Fill in our request form and our specialists will contact you soon.

  Request Form  


  • All prices are already discounted.
  • VAT is excluded.
  • Shipping costs and dry ice fee are included.
  • This offer cannot be combined with any other promotion or quotation.
  • This action is valid until March 31st, 2020.
  • General conditions of sales apply.
  • There is no cash alternative to the reward.
  • This offer is only available in following countries: Austria, Belgium, France, Cyprus, Czech Republic, Germany, Greece, Hungary, Ireland, Israel, Italy, Luxembourg, Monaco, Netherlands, Poland, Portugal, Slovak Republic, Slovenia, Spain, Switzerland and United Kingdom.


Support Area

We use cookies to ensure the best experience on our website. By continuing to use this website, you consent to our cookie policy.